Algo version: 0.98b
China Pioneer Pharma is listed at the HKSE Exchange
China Pioneer Pharma [1345.HK]
HKSE Sector: Healthcare Industry:Pharmaceutical Retailers

Is China Pioneer Pharma stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, China Pioneer Pharma pays dividends. Last time was Friday 15th of November 2024 where the investors holding the stock on Wednesday 30th of October 2024 were paid HKD0.048 per share. Over the last 20 times between 2014 and 2024, China Pioneer Pharma has paid HKD1.196 with an average of HKD0.06 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for China Pioneer Pharma 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD0.610, you would have made a profit of HKD1.420 per share or 232.79%

No, the average daily trading liquidity for China Pioneer Pharma is HKD60 079 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

China Pioneer Pharma has no real debt, which is good in periods of high inflation. China Pioneer Pharma has a good net profit margin of 9.30% and should have high tolerances against inflation.

We have calculated the inflation risk for China Pioneer Pharma to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.